Researchers have developed MoLRSI, an AI agent designed to recursively improve its molecular discovery workflows. This agent learns from past experiences and feedback to optimize both its search strategies and the architecture of its workflows. In antibiotic discovery, MoLRSI achieved a 15.9% hit rate, significantly outperforming a previous expert-led workflow. It also succeeded in de novo peptide-MHC binder design where another AI, Claude Science, failed. AI
IMPACT Demonstrates a novel approach to AI self-improvement in scientific discovery, potentially accelerating drug and peptide development.
RANK_REASON Publication of a research paper detailing a new AI agent and its performance on molecular discovery tasks. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →